ARIAD to Present at the Jefferies 2016 Global Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)– ARIAD
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Jefferies 2016 Global Healthcare Conference being held in
New York City. Paris Panayiotopoulos, president and chief executive
officer, will provide an overview of the Company’s business on
Wednesday, June 8, 2016 at 11:00 a.m. (ET).

The ARIAD presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company’s website at http://www.ariad.com/investor.
A replay of the presentation will also be available and archived on the
site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is an orphan oncology company focused on transforming the lives of
cancer patients with breakthrough medicines. ARIAD is working on new
medicines to advance the treatment of various forms of chronic and acute
leukemia, lung cancer and other difficult-to-treat orphan cancers. ARIAD
utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer
medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160601005189/en/